LAK to CIK continuum in glioma immunotherapy: a systematic review of efficacy and safety outcomes.

Hamidi S, Morsali S, Ghannadikhosh P, Darvishi A, Nour MA, Zafarabadi S, Rahmani M, Doustvandi MA, Aghebati-Maleki L

Open source

DOI
10.1186/s12967-026-08466-7
Published
2026 Jun 22
Container
Journal of translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12967-026-08466-7,
  title = {LAK to CIK continuum in glioma immunotherapy: a systematic review of efficacy and safety outcomes.},
  author = {Hamidi S and Morsali S and Ghannadikhosh P and Darvishi A and Nour MA and Zafarabadi S and Rahmani M and Doustvandi MA and Aghebati-Maleki L},
  year = {2026},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-026-08466-7},
  url = {https://doi.org/10.1186/s12967-026-08466-7}
}

RIS

TY  - JOUR
TI  - LAK to CIK continuum in glioma immunotherapy: a systematic review of efficacy and safety outcomes.
AU  - Hamidi S
AU  - Morsali S
AU  - Ghannadikhosh P
AU  - Darvishi A
AU  - Nour MA
AU  - Zafarabadi S
AU  - Rahmani M
AU  - Doustvandi MA
AU  - Aghebati-Maleki L
PY  - 2026
JO  - Journal of translational medicine
DO  - 10.1186/s12967-026-08466-7
UR  - https://doi.org/10.1186/s12967-026-08466-7
ER  - 

APA

S, H., S, M., P, G., A, D., MA, N., S, Z., M, R., MA, D., & L, A. (2026). LAK to CIK continuum in glioma immunotherapy: a systematic review of efficacy and safety outcomes.. Journal of translational medicine. https://doi.org/10.1186/s12967-026-08466-7

Source records